h-hydrogen

Background: Glomerular filtration speed (GFR) can be exact by measuring renal endorsement of the radiocontrast spokesman iothalamate. In vogue analytic methods for quantifying iothalamate concentrations in plasma and urine using melted chromatography or capillary electrophoresis set up limitations such as crave dissection times and susceptibility to interferences. We developed a liquid chromatography–tandem throng spectrometry (LC-MS/MS) method to speechless these limitations.

Methods: Urine and plasma samples were deproteinized using acetonitrile and centrifugation. The supernatant was diluted in be inconsistent and analyzed by LC-MS/MS using a water:methanol gradient. We monitored 4 multiple counterbalance monitoring transitions: m/z 614.8–487.0, 614.8–456.0, 614.8–361.1, and 614.8–177.1. We compared the results to those obtained via our banner capillary electrophoresis (CE-UV) on samples from 53 patients undergoing clinical GFR testing.

Results: Employing saving was 90%–110% in both urine and plasma matrices. Imprecision was ≤15% for the m/z 614.8–487.0 and 614.8–456.0 transitions past a 10-day era at 1 mg/L. Method weighing for 159 patient samples (53 clearances) provided the following Passing–Bablok regressions: plasma iothalamate LC-MS/MS (y) vs CE-UV (x), y = 0.99x + 0.36; urine iothalamate LC-MS/MS vs CE-UV, y = 1.01x + 0.31; corrected GFR LC-MS/MS vs CE-UV, y = 1.00x + 0.00. Interfering substances prevented on the mark iothalamate quantification by CE-UV in 2 patients, whereas these samples could be analyzed by LC-MS/MS.

Conclusions: Iothalamate can be quantified by LC-MS/MS for GFR square. This method circumvents the right stuff problems with interfering substances that sometimes confound accurate GFR determinations.